2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene CAS NO.1030825-20-7
| inoa | 2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene | ||
| CAS NO. | 1030825-20-7 | ||
| ʻĀpana Molekala | C18H14BrFS | Kaumaha Molecular | 361.27 |
| MDL No. | MFCD21496340 | EINECS | 807-103-7 |
| MP | 103 °C | BP | 438.3±40.0 °C(Wānana ʻia) |
| ʻO ka mānoanoa | 1.388 g/cm3(Wanamua) | Hōʻike Hōʻike | NA |
| FP | NA | Kūlana mālama | E mālama ma kahi pouli, Hoʻopaʻa ʻia i kahi maloʻo, Ke ana wela o ka lumi |
| Ka nana aku | Paʻa keʻokeʻo i ke keʻokeʻo | ||
| Maemae | 98% | ||
| Palapala noi | ʻO Canagliflozin intermediate, hiki ke hoʻohana ʻia e mālama i nā poʻe maʻi me ka maʻi diabetes type 2 | ||
| Hiki ke hoolako | 2-(5-BroMo-2-Methylbenzyl) -5-(4-fluorophenyl) thiophene CAS NO.1030825-20-7 ʻo kā mākou huahana hana maʻamau, inā makemake ʻoe i kahi laʻana liʻiliʻi a i ʻole ka ukana nui ʻoi aku ma mua o tonnage, kā mākou hui. hiki ke hoolako ia mea ma ke ano | ||
| Inā makemake ʻoe i ka 2-(5-BroMo-2-Methylbenzyl) -5-(4-fluorophenyl) thiophene CAS NO.1030825-20-7, e ʻoluʻolu e leka uila iā mākou, a e hāʻawi mākou iā ʻoe i nā huahana maikaʻi loa. kumukūʻai kūpono a me ka lawelawe maikaʻi loa, e manaʻo ana i kā mākou hui. | |
| | |
| Kelepona No. | +86 139 6251 3054 +86 136 2174 3828 |
ʻO nā huahana i heluʻia e ka hui e pili ana i nā patents, kahi wale nō no ka noiʻi a me ka hoʻomohalaʻana aʻaʻole no ke kūʻai aku;e kūʻai ʻia aku nā huahana i hoʻopaʻa ʻia e like me nā kānāwai Kina a me nā kānāwai o ka ʻāina i kūʻai ʻia ai lākou, a ʻaʻole kūpono nā huahana a pau no ka hoʻohana kanaka.Inā kūʻai ʻia, e lilo lākou i ʻāina hōʻino patent, na ka mea kūʻai aku e lawe i nā pilikia pili.
E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou


.jpeg)


![(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran CAS NO.915095-89-5](http://cdn.globalso.com/shlzpharma/915095-89-5.jpeg)

![2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS NO.898566-17-1](http://cdn.globalso.com/shlzpharma/898566-17-1.jpeg)
